Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9
3 min) increases particulate cGMP- and cilostamide-inhibited
Saracatinib potently inhibits the proliferation of Src3T3 mouse fibroblasts and demonstrates variable antiproliferative activity in a range of human cancer cell lines containing endogenous Src
HeLa and HT-29 cells) treatment significantly increases the cytotoxicity of DNA damage
and an inhibitor of WWP1 (WW domain-containing ubiquitin E3 ligase 1)
Approved API for cancer therapeutic use is doxorubicin HCl
Elacridar tilonium Bromide 3 min) increases particulate cGMP-Elacridar, also known as GF120918A, is a P glycoprotein (P gp) inhibitor, and has been used both in vitro and in vivo as a tool inhibitor of P glycoprotein (Pgp) to investigate the role of transporters in the disposition of various test molecules. In vitro, GF120918A demonstrated high plasma protein binding across species, although a definitive protein binding evaluation was precluded by poor recovery, particularly in buffer and in mouse, rat, and dog
US$ 250.00
US$ 200.00
US$ 200.00
US$ 225.00
US$ 150.00
US$ 190.00
US$ 200.00
US$ 1224.50
US$ 200.00